Rod Balhorn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rod Balhorn has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Michele Corzett
Chemistry, Materials and Life Sciences and
2 shared publicationsAdam Zemla
Computations, Lawrence Livermore National Laboratory, Livermore, California
1 shared publicationArutselvan Natarajan
Radiodiagnosis and Therapy Laboratory and
1 shared publicationCheryl Kramer
Lawrence Livermore National Laboratory, Biology and Biotechnology Research Program, University of California, Livermore, California
1 shared publicationFelice C. Lightstone
Chemistry, Materials and Life Sciences and
1 shared publicationGary Mirick
Radiodiagnosis and Therapy Laboratory and
1 shared publication
Latest Publications
- Open Access
- 15 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (18) , 5621s-5628s
Selective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia
Purpose: More than two decades of research and clinical trials have shown radioimmunotherapy to be a promising approach for treating various forms of cancer. Lym-1 antibody, which binds selectively to HLA-DR10 on malignant B-cell lymphocytes, has proved to be effective in delivering radionuclides to non–Hodgkin's lymphoma and leukemia. Using a new approach to create small synthetic molecules that mimic the targeting properties of the Lym-1 antibody, a prototype, selective high-affinity ligand (SHAL), has been developed to bind to a unique region located within the Lym-1 epitope on HLA-DR10.
- 15 September 2007
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (18) , 5621s-5628s
Open AccessSelective High-Affinity Ligand Antibody Mimics for Cancer Diagnosis and Therapy: Initial Application to Lymphoma/Leukemia
Purpose: More than two decades of research and clinical trials have shown radioimmunotherapy to be a promising approach for treating various forms of cancer. Lym-1 antibody, which binds selectively to HLA-DR10 on malignant B-cell lymphocytes, has proved to be effective in delivering radionuclides to non–Hodgkin's lymphoma and leukemia. Using a new approach to create small synthetic molecules that mimic the targeting properties of the Lym-1 antibody, a prototype, selective high-affinity ligand (SHAL), has been developed to bind to a unique region located within the Lym-1 epitope on HLA-DR10.
- Top Cited PapersOpen Access
- 1 January 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (9) , 227
The protamine family of sperm nuclear proteins
The protamines are a diverse family of small arginine-rich proteins that are synthesized in the late-stage spermatids of many animals and plants and bind to DNA, condensing the spermatid genome into a genetically inactive state. Vertebrates have from one to 15 protamine genes per haploid genome, which are clustered together on the same chromosome. Comparison of protamine gene and amino-acid sequences suggests that the family evolved from specialized histones through protamine-like proteins to the true protamines. Structural elements present in all true protamines are a series of arginine-rich DNA-anchoring domains (often containing a mixture of arginine and lysine residues in non-mammalian protamines) and multiple phosphorylation sites. The two protamines found in mammals, P1 and P2, are the most widely studied. P1 packages sperm DNA in all mammals, whereas protamine P2 is present only in the sperm of primates, many rodents and a subset of other placental mammals. P2, but not P1, is synthesized as a precursor that undergoes proteolytic processing after binding to DNA and also binds a zinc atom, the function of which is not known. P1 and P2 are phosphorylated soon after their synthesis, but after binding to DNA most of the phosphate groups are removed and cysteine residues are oxidized, forming disulfide bridges that link the protamines together. Both P1 and P2 have been shown to be required for normal sperm function in primates and many rodents.
- 1 January 2007
- Published by Springer Nature in Genome Biology
- Vol. 8 (9) , 227
Top Cited PapersOpen AccessThe protamine family of sperm nuclear proteins
The protamines are a diverse family of small arginine-rich proteins that are synthesized in the late-stage spermatids of many animals and plants and bind to DNA, condensing the spermatid genome into a genetically inactive state. Vertebrates have from one to 15 protamine genes per haploid genome, which are clustered together on the same chromosome. Comparison of protamine gene and amino-acid sequences suggests that the family evolved from specialized histones through protamine-like proteins to the true protamines. Structural elements present in all true protamines are a series of arginine-rich DNA-anchoring domains (often containing a mixture of arginine and lysine residues in non-mammalian protamines) and multiple phosphorylation sites. The two protamines found in mammals, P1 and P2, are the most widely studied. P1 packages sperm DNA in all mammals, whereas protamine P2 is present only in the sperm of primates, many rodents and a subset of other placental mammals. P2, but not P1, is synthesized as a precursor that undergoes proteolytic processing after binding to DNA and also binds a zinc atom, the function of which is not known. P1 and P2 are phosphorylated soon after their synthesis, but after binding to DNA most of the phosphate groups are removed and cysteine residues are oxidized, forming disulfide bridges that link the protamines together. Both P1 and P2 have been shown to be required for normal sperm function in primates and many rodents.
- 23 September 1999
- Published by Wiley in Molecular Reproduction and Development
- Vol. 54 (3) , 273-282
Analysis of hamster protamines: Primary sequence and species distribution
- 23 September 1999
- Published by Wiley in Molecular Reproduction and Development
- Vol. 54 (3) , 273-282
Analysis of hamster protamines: Primary sequence and species distribution